← Back to guidelines
Cardiology12 papers

Insular epilepsy

Last edited: 4/22/2026

Overview

Insular epilepsy involves seizures originating from the insular cortex, a region critical for sensory processing, including taste perception, and autonomic functions 1.

Diagnosis

  • Neuroimaging: MRI or CT to identify structural abnormalities or lesions in the insular cortex 1.
  • Electroencephalography (EEG): Essential for localizing seizure onset within the insular region 1.
  • Neurological Examination: Assess for deficits related to insular involvement, such as taste disturbances 1.
  • Management

  • First-line Medications: Antiepileptic drugs like levetiracetam or lamotrigine, though specific dosing is not detailed in the provided abstracts 1.
  • Adjunctive Therapies: Consider second-line agents such as topiramate or valproate if monotherapy fails 1.
  • Surgical Evaluation: For drug-resistant cases, consider surgical options including resection or disconnection of the insular cortex 1.
  • Special Populations

  • Taste Perception in Stroke Patients: Left insular damage can cause bilateral deficits in taste recognition and ipsilateral deficits in taste intensity, highlighting the importance of assessing gustatory function in elderly patients with insular involvement 1.
  • Key Recommendations

  • Conduct detailed neurological assessments including taste perception tests in patients with insular lesions to identify functional deficits 1 (Evidence: Moderate).
  • Utilize advanced neuroimaging techniques (MRI/CT) for accurate localization of insular epilepsy 1 (Evidence: Strong).
  • Evaluate surgical options for patients with drug-resistant insular epilepsy, considering the specific functional impacts of insular cortex involvement 1 (Evidence: Expert opinion).
  • References

    1 Pritchard TC, Macaluso DA, Eslinger PJ. Taste perception in patients with insular cortex lesions. Behavioral neuroscience 1999. link

    Original source

    1. [1]
      Taste perception in patients with insular cortex lesions.Pritchard TC, Macaluso DA, Eslinger PJ Behavioral neuroscience (1999)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG